Propranolol for Management of Palpitations
Propranolol is effective for managing palpitations, particularly in patients with tachyarrhythmias, atrial fibrillation, or conditions with increased adrenergic tone. 1, 2, 3
Mechanism of Action and Efficacy
Propranolol works as a nonselective beta-adrenergic receptor-blocking agent that:
- Competes with beta-adrenergic stimulating agents for receptor sites
- Decreases chronotropic (heart rate) and inotropic (contractility) responses
- Reduces oxygen requirements of the heart during exertion
- Blocks catecholamine-induced increases in heart rate and blood pressure 3
Clinical Applications for Palpitations
First-Line Therapy for:
- Palpitations associated with atrial fibrillation (AF) (Class I recommendation) 1, 2
- Junctional tachycardia (Class IIa recommendation) 4
- Palpitations related to high adrenergic states (e.g., anxiety, post-operative states) 2, 5
- Supraventricular tachycardias (SVTs) 6
Dosing Recommendations:
- Acute management: 0.15 mg/kg IV (for rapid control) 2
- Chronic management: Starting at 30-60 mg daily in divided doses, with long-acting formulations available
- Maximum dose: 40-160 mg in divided or single doses with long-acting formulations 6
Patient Selection Considerations
Best candidates:
- Patients with palpitations due to AF or SVT
- Patients with coexisting anxiety or migraine 5
- Patients with high adrenergic tone states 2
Use with caution in:
- Patients with COPD or bronchospasm (calcium channel blockers preferred) 7
- Patients with decompensated heart failure 2, 6
- Patients with hypotension 6
- Patients with AV block greater than first degree 6
Monitoring and Side Effects
Common side effects:
- Hypotension
- Bradycardia
- Bronchospasm
- Heart block
- Worsening heart failure in predisposed patients 6
Monitoring recommendations:
- Heart rate and blood pressure
- Signs of bronchospasm in susceptible patients
- Exercise tolerance (propranolol may blunt appropriate heart rate response) 1
Alternative Options
When propranolol is contraindicated or not tolerated:
- Calcium channel blockers (diltiazem, verapamil) - especially in COPD patients 7
- Digoxin - for rate control at rest in sedentary patients 2
- Amiodarone - when other measures are unsuccessful 2
Special Considerations
- In patients with palpitations related to Post-Acute Sequelae of SARS-CoV-2 infection (PASC), low-dose beta-blockers including propranolol may help control symptoms 5
- Some patients may experience exacerbation of panic disorder with propranolol 8
- A biphasic dose-response has been observed in some patients with ventricular arrhythmias 9
Propranolol remains a valuable and effective option for managing palpitations across various clinical scenarios, with strong evidence supporting its use in reducing symptoms and improving quality of life when appropriately prescribed.